[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556738":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":33,"centralContacts":37,"locations":46,"responsibleParty":64,"collaborators":22,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":70,"acronym":22,"eligibilityCriteria":71,"healthyVolunteers":68,"sex":72,"minAge":73,"maxAge":74,"enrollmentInfo":75,"targetDuration":22,"studyType":78,"phases":79,"briefSummary":81,"conditions":82,"keywords":84,"overallStatus":48,"whyStopped":22,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Virginia Commonwealth University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Luminopia VR headset treatment","EXPERIMENTAL","Using Dichoptic Therapy to Improve Intermittent Exotropia Control in children ages 4-7",[13,14,15],"Device: Luminopia, a virtual reality headset","Other: Paper pre- survey","Other: Paper Survey",[17,23,27],{"type":18,"name":19,"description":20,"armGroupLabels":21,"otherNames":22},"DEVICE","Luminopia, a virtual reality headset","Subjects will be provided with the equipment to use in their homes for six hours usage per week (1 hour 6 days a week), for 12 weeks.",[9],null,{"type":6,"name":24,"description":25,"armGroupLabels":26,"otherNames":22},"Paper pre- survey","Pre-survey to be completed by the parent and child. Questions may be skipped. Survey developed by the study team",[9],{"type":6,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"Paper Survey","Post-survey to be completed by the parent and child. Questions may be skipped. Survey developed by the study team",[9],[32],"Paper post-survey",[34],{"name":35,"affiliation":5,"role":36},"Evan Silverstein","PRINCIPAL_INVESTIGATOR",[38,42],{"name":35,"role":39,"phone":40,"phoneExt":22,"email":41},"CONTACT","804-828-2467","evan.silverstein@vcuhealth.org",{"name":43,"role":39,"phone":44,"phoneExt":22,"email":45},"Emilia Varrone","804-828-9315","emilia.varrone@vcuhealth.org",[47],{"facility":5,"status":48,"city":49,"state":50,"zip":51,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"RECRUITING","Richmond","Virginia","23298","United States","US",{"type":55,"coordinates":56},"Point",[57,58],-77.46026,37.55376,{"lat":58,"lon":57},[61,63],{"name":62,"role":39,"phone":40,"phoneExt":22,"email":41},"Evan Silverstein, MD",{"name":43,"role":39,"phone":44,"phoneExt":22,"email":45},{"type":65,"investigatorFullName":22,"investigatorTitle":22,"investigatorAffiliation":22,"oldNameTitle":22,"oldOrganization":22},"SPONSOR","100556738","using-dichoptic-therapy-to-treat-intermittent-exotropia-100556738",false,"NCT06529016","Using Dichoptic Therapy to Treat Intermittent Exotropia","Inclusion Criteria:\n\n* Diagnosed with IXT\n* one eye that is their preferred eye\n* ages 4-7\n* distance control scores of \\\u003C= 4\n\nExclusion Criteria:\n\n* distance control scores of 5\n* patients with visual acuity with vision that is worse in one eye by greater than two lines\n* no preferred eye\n* patients who would be unable to tolerate wearing the headset for 1 hour\u002Fday, 6 days\u002Fweek, for 12 weeks.","ALL","4 Years","7 Years",{"count":76,"type":77},20,"ESTIMATED","INTERVENTIONAL",[80],"NA","Intermittent exotropia is difficult to treat. The mainstay of treatment involves surgery, and in one long-term study authors found that as many as 60% of IXT required at least one re-operation.Patching of the non-dominant eye has also been tested in a large, multi-center randomized control trial and was not found to have a large benefit. More non-surgical treatment modalities are critical to improve the care in this condition.",[83],"Exotropia Intermittent",[85],"Dichoptic therapy","2025-10-06",{"date":88,"type":89},"2025-10-08","ACTUAL",{"date":91,"type":89},"2024-07-26",{"date":93,"type":77},"2026-06",{"name":5,"class":6},1]